CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 76 filers reported holding CASCADIAN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,439,000 | +1.6% | 389,041 | +12.2% | 0.00% | -100.0% |
| Q3 2017 | $1,417,000 | +24.6% | 346,602 | +13.2% | 0.00% | – |
| Q2 2017 | $1,137,000 | +8.6% | 306,179 | +21.1% | 0.00% | – |
| Q1 2017 | $1,047,000 | +110.2% | 252,934 | +118.8% | 0.00% | – |
| Q4 2016 | $498,000 | – | 115,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|